Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of β-thalassemia and sickle cell disease.
Negre O, Bartholomae C, Beuzard Y, Cavazzana M, Christiansen L, Courne C, Deichmann A, Denaro M, de Dreuzy E, Finer M, Fronza R, Gillet-Legrand B, Joubert C, Kutner R, Leboulch P, Maouche L, Paulard A, Pierciey FJ, Rothe M, Ryu B, Schmidt M, von Kalle C, Payen E, Veres G.
Negre O, et al. Among authors: leboulch p.
Curr Gene Ther. 2015;15(1):64-81. doi: 10.2174/1566523214666141127095336.
Curr Gene Ther. 2015.
PMID: 25429463
Free PMC article.